Overview

Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity

Status:
Recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
Bacterial vaginosis (BV) is the most common cause of vaginal discharge among repro-ductive aged women. It is been linked to adverse maternal and neonatal outcomes. Our objective is to evaluate if the use of a single dose of metronidazole in women with BV at time of delivery reduces infectious morbidities
Phase:
Phase 1
Details
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Treatments:
Metronidazole